NEWS

In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement: “As this global pandemic continues to wreak havoc, we must stand behind the scientists and researchers working tirelessly to eradicate this devastating disease. Nothing is more disheartening or disturbing than to see Dr. Anthony Fauci,…

Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses. “The planned work…

The first phase of a Covid-19 vaccine trial at Emory University and other locations produced “very encouraging” results, according to trial investigators. The experimental vaccine manufactured by Moderna Inc., mRNA-1293, produced “a good immune response,” and trial participants suffered no serious adverse events, according to results presented Tuesday afternoon by Emory reseachers and published at the same time…

STRONGER Brings Together Science, Experts and the American Public, Targeting Misinformation Spread Against Science, Medicine, and Vaccines NEW YORK, July 15, 2020 /PRNewswire/ — PGP, (The Public Good Projects), a public health nonprofit responsible for some of the nation’s most successful health campaigns, announces today the launch of STRONGER, a first-of-its-kind national advocacy campaign against misinformation and for vaccines. While previous…

The U.S. government will buy Becton, Dickinson and Co’s COVID-19 testing devices and kits, the company said on Wednesday, as it ramps up its testing for the virus that has been spreading at an alarming rate. The U.S. Department of Health and Human Services has agreed to buy 2,000 of its BD Veritor Plus Systems…

BD (Becton, Dickinson and Company (BDX)) (NYSE: BDX), a leading global medical technology company, announced today a commitment from the U.S. Department of Health and Human Services (HHS) to purchase BD diagnostic solutions in expanding access to rapid point-of-care testing for COVID-19 through a broad, decentralized network of testing instrumentation. HHS has committed to purchase…